GUANGDONG MARUBI BIOTECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.29 CNY | +1.25% |
|
+2.46% | +11.95% |
| Sales 2023 | 2.23B 307M 25.61B | Sales 2024 * | 2.88B 398M 33.18B | Capitalization | 11.34B 1.57B 131B |
|---|---|---|---|---|---|
| Net income 2023 | 259M 35.74M 2.98B | Net income 2024 * | 369M 50.93M 4.25B | EV / Sales 2023 | 4.18 x |
| Net cash position 2023 | 824M 114M 9.49B | Net cash position 2024 * | 1.14B 157M 13.12B | EV / Sales 2024 * | 3.54 x |
| P/E ratio 2023 |
38.9
x | P/E ratio 2024 * |
30.6
x | Employees | 1,060 |
| Yield 2023 |
2.06% | Yield 2024 * |
1.02% | Free-Float | 19.18% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.25% | ||
| 1 week | +2.46% | ||
| Current month | -3.12% | ||
| 1 month | -3.71% | ||
| 3 months | -2.11% | ||
| 6 months | +20.90% | ||
| Current year | +11.95% |
1 week
27.20
29.52
1 month
26.8529.70
Current year
25.0133.75
1 year
22.9641.30
3 years
19.1062.26
5 years
19.1092.89
10 years
19.1092.89
| Managers | Title | Age | Since |
|---|---|---|---|
Huai Qing Sun
CEO | Chief Executive Officer | 55 | 02/02/02 |
Kai Hui Wang
DFI | Director of Finance/CFO | 53 | 01/06/01 |
Chao Wan Guo
CTO | Chief Tech/Sci/R&D Officer | 41 | 01/19/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yong Cao
BRD | Director/Board Member | 58 | 23/23/23 |
Huai Qing Sun
CEO | Chief Executive Officer | 55 | 02/02/02 |
Kai Hui Wang
DFI | Director of Finance/CFO | 53 | 01/06/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 28.29 | +1.25% | 2,430,137 |
| 25/24/25 | 27.94 | -1.48% | 2,791,050 |
| 24/24/24 | 28.36 | -3.70% | 4,175,200 |
| 23/24/23 | 29.45 | +4.73% | 3,572,473 |
| 22/24/22 | 28.12 | +1.85% | 1,898,688 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes
Guangdong Marubi Biotechnology Co., Ltd is a China-based company mainly engaged in development and manufacture, design, production and sales of various cosmetics, as well as the provision of related services. The Company's products mainly include eye care products, skin cleansing products, skin care products (cream lotion and mask), make-up products and others. The Company's brands mainly include Maru, Cac and Passional Lover. The Company mainly conducts its businesses in domestic market.
Sector
Personal Products
Calendar
27/04/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
28.29
CNY
Average target price
30.93
CNY
Spread / Average Target
+9.34%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.95% | 1.57B | |
| -3.33% | 249B | |
| +10.09% | 18.86B | |
| 0.00% | 17.37B | |
| -1.32% | 10.65B | |
| -7.73% | 10.26B | |
| +3.86% | 6.72B | |
| +9.76% | 5.94B | |
| -0.06% | 4.55B | |
| -16.98% | 3.83B |
- Stock Market
- Equities
- 603983 Stock
